| A Phase 1, First Time in Humans Study of NST-1024 (NCT04630366) | NorthSea Therapeutics B.V. | 2020-10-27 |
| A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 2 (NCT04611971) | Janssen Research & Development, LLC | 2020-10-27 |
| Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer (NCT04250545) | National Cancer Institute (NCI) | 2020-10-26 |
| Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers (NCT04618263) | Syndeio Biosciences, Inc | 2020-10-26 |
| Phase 1/2 Clinical Study of TPX-115 in Patients With Partial-Thickness Rotator Cuff Tear (NCT04470167) | Tego Science, Inc. | 2020-10-26 |
| Phase I Study of pCAR-19B in the Treatment of Adult CD19-positive Relapsed/Refractory B-ALL (NCT04888442) | Chongqing Precision Biotech Co., Ltd | 2020-10-26 |
| A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer (NCT04516447) | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | 2020-10-26 |
| Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma (NCT05333302) | Belarusian Research Center for Pediatric Oncology, Hematology and Immunology | 2020-10-26 |
| Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC (NCT04610671) | H. Lee Moffitt Cancer Center and Research Institute | 2020-10-26 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese Adults With Type 2 Diabetes Mellitus (NCT04552470) | Pfizer | 2020-10-26 |
| Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms (NCT04541082) | Jazz Pharmaceuticals | 2020-10-26 |
| A Phase I Study of TQB728 Tablets on Tolerance and Pharmacokinetics (NCT04523285) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-10-26 |
| Safety of Inhaled Hydrogen Gas Mixtures in Healthy Volunteers (NCT04046211) | Boston Children's Hospital | 2020-10-26 |
| GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy (NCT04601402) | Genome & Company | 2020-10-26 |
| Safety, Tolerability and Pharmacokinetics of FTX-6058 (NCT04586985) | Fulcrum Therapeutics | 2020-10-26 |
| Pharmacokinetics and Pharmacodynamics of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplantation (NCT04868786) | Seoul National University Hospital | 2020-10-26 |
| Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's Disease (NCT04566003) | Genentech, Inc. | 2020-10-26 |
| A Single and Multiple Dose Study of Lemborexant in Healthy Chinese Participants (NCT04555733) | Eisai Co., Ltd. | 2020-10-26 |
| Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects (NCT04606537) | KBP Biosciences | 2020-10-24 |
| Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product (NCT04230070) | Laboratorios Andromaco S.A. | 2020-10-24 |
| Single and Multiple Ascending Dose Study of CORT125329 in Healthy Participants (NCT04672512) | Corcept Therapeutics | 2020-10-23 |
| A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy (NCT04418297) | Celltrion | 2020-10-23 |
| Safety and Efficacy of ThisCART22 in Patients With Refractory or Relapsed B Cell Malignancies (NCT04601181) | Fundamenta Therapeutics, Ltd. | 2020-10-23 |
| Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization (NCT04439006) | Jennifer Woyach | 2020-10-23 |
| Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection (NCT04581473) | CARsgen Therapeutics Co., Ltd. | 2020-10-23 |
| Talazoparib and Gemtuzumab Ozogamicin for the Treatment of CD33 Positive Relapsed or Refractory Acute Myeloid Leukemia (NCT04207190) | Roswell Park Cancer Institute | 2020-10-23 |
| 16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer (NCT04150731) | University of Aarhus | 2020-10-23 |
| CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell Lymphoma (NCT04578600) | Joseph Tuscano | 2020-10-23 |
| Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers (NCT04404595) | CARsgen Therapeutics Co., Ltd. | 2020-10-23 |
| Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico. (NCT04440774) | University of Oxford | 2020-10-23 |
| Single Ascending Dose Study of Intravenous Infusion of PF 07304814 in Healthy Adult Participants (NCT04627532) | Pfizer | 2020-10-23 |
| Effects of Topical Insulin on Levels of Tear Inflammatory Mediators (NCT04877210) | Universiti Kebangsaan Malaysia Medical Centre | 2020-10-22 |
| A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension (NCT04503733) | Gmax Biopharm LLC. | 2020-10-22 |
| A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects (NCT04536337) | Aligos Therapeutics | 2020-10-22 |
| Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis (NCT04262167) | University of North Carolina, Chapel Hill | 2020-10-22 |
| Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/Velpatasvir (NCT04382404) | Catherine Anne Chappell | 2020-10-22 |
| A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-M23, a CAR-T Cell Therapy Targeting MSLN in Patients With Relapsed and Refractory Epithelial Ovarian Cancer (NCT04562298) | Shanghai East Hospital | 2020-10-21 |
| Therapeutic Plasma Exchange in Adult Patients With Severe Sepsis (NCT04057872) | Alberta Health Services, Calgary | 2020-10-21 |
| A Study of AK112 for Advanced Solid Tumors (NCT04597541) | Akeso | 2020-10-21 |
| Safety, Tolerability and Pharmacokinetics of Felbinac Trometamol Eye Drops (NCT05085106) | Beijing Tongren Hospital | 2020-10-21 |
| Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors (NCT04640480) | SN BioScience | 2020-10-21 |
| A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine (NCT04575181) | Novo Nordisk A/S | 2020-10-21 |
| Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects. (NCT05123976) | Joint Stock Company "Farmak" | 2020-10-21 |
| A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma (NCT04464759) | Ravi Amaravadi, MD | 2020-10-21 |
| REVEAL Biomarkers of Engraftment After Alternative Donor HSCT (NCT03541889) | University of Oklahoma | 2020-10-21 |
| A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus (NCT04235959) | Eli Lilly and Company | 2020-10-21 |
| A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 1 (NCT04589026) | Janssen Research & Development, LLC | 2020-10-21 |
| Clinical Study of BCG Vaccine for Intradermal Injection (NCT04563273) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2020-10-21 |
| Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants (NCT04526210) | Alexion Pharmaceuticals, Inc. | 2020-10-21 |
| TACE Combined With Sintilimab and Bevacizumab for Unresectable HCC (NCT04592029) | Second Affiliated Hospital of Guangzhou Medical University | 2020-10-21 |
| Phase I Clinical Protocol of BCG-PPD in Healthy People (NCT04593771) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2020-10-21 |
| To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder (NCT04440696) | Grand Life Science (Liaoning) Co., Ltd. | 2020-10-21 |
| Study of the Metabolism of Danicopan in Healthy Adults (NCT04609696) | Alexion Pharmaceuticals, Inc. | 2020-10-20 |
| A Study to Investigate the Pharmacokinetic Profile of Oral AB680 in Healthy Volunteers (NCT04575311) | Arcus Biosciences, Inc. | 2020-10-20 |
| Bioequivalence Study of Eldecalcitol Soft Capsule in Healthy Chinese Subjects (NCT05406050) | The Affiliated Hospital of Qingdao University | 2020-10-20 |
| A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects (NCT04512872) | Celltrion | 2020-10-20 |
| A Single Dose Study About the Influence of Food on the Oral Bioavailability of Ladarixin Capsule in Healthy Volunteers (NCT04854642) | Dompé Farmaceutici S.p.A | 2020-10-20 |
| MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer (NCT04729543) | Erasmus Medical Center | 2020-10-20 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection (NCT06081712) | TenNor Therapeutics (Suzhou) Limited | 2020-10-20 |
| Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia (NCT04723901) | Shenzhen University General Hospital | 2020-10-20 |
| ICMNC-HF. IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients (NCT03145402) | SCARM Institute, Tabriz, Iran | 2020-10-20 |
| Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19 (NCT04545008) | Prisma Health-Upstate | 2020-10-20 |
| Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis (NCT04610359) | Asan Medical Center | 2020-10-20 |
| A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients (NCT04432766) | Bio-Thera Solutions | 2020-10-20 |
| Safety and Tolerability Evaluation of MaaT033 (NCT04150393) | MaaT Pharma | 2020-10-20 |
| Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults (NCT04590430) | HiFiBiO Therapeutics | 2020-10-20 |
| A Study of LY3509754 in Healthy Non-Japanese and Japanese Participants (NCT04586920) | Eli Lilly and Company | 2020-10-20 |
| A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body (NCT04590937) | Boehringer Ingelheim | 2020-10-20 |
| Dual Target CAR-T Cells in B-cell Lymphoma (NCT04723914) | YuLi | 2020-10-20 |
| Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity Study of SB16 in Healthy Male Subjects (NCT04621318) | Samsung Bioepis Co., Ltd. | 2020-10-19 |
| To Evaluate the Pharmacokinetics and Safety of Yimitasvir Phosphate Capsules in Subjects With Moderate and Severe Liver Function Impairment and in Healthy Subjects (NCT04552808) | Sunshine Lake Pharma Co., Ltd. | 2020-10-19 |
| A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol (NCT04600505) | AstraZeneca | 2020-10-19 |
| WeCareAdvisor: A Web-Based Tool to Improve Quality of Life for Military Veterans With Dementia and Their Caregivers (NCT04587583) | University of Michigan | 2020-10-19 |
| To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003 (NCT04592835) | Daewoong Pharmaceutical Co. LTD. | 2020-10-19 |
| Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046) (NCT04551950) | EMD Serono Research & Development Institute, Inc. | 2020-10-19 |
| Phase 1b/II Trial of Pembrolizumab Plus IMRT in Stage III/IV Carcinoma of Anus (NCT04046133) | Cardiff University | 2020-10-19 |
| A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis (NCT04594928) | Lakefront Biotherapeutics NV | 2020-10-19 |
| Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer (NCT04870840) | M.D. Anderson Cancer Center | 2020-10-19 |
| A Study in Healthy Men to Test How BI 1358894 is Taken up and Handled by the Body (NCT04567316) | Boehringer Ingelheim | 2020-10-19 |
| COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers (NCT04591717) | ImmunityBio, Inc. | 2020-10-19 |
| A Phase Ib / IIA Study of AL8326 in Small Cell Lung Cancer (NCT04890795) | Advenchen Laboratories Nanjing Ltd. | 2020-10-19 |
| Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC (NCT04476797) | Galera Therapeutics, Inc. | 2020-10-18 |
| Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure (NCT04384653) | SQ Innovation, Inc. | 2020-10-17 |
| FT538 in Subjects With Advanced Hematologic Malignancies (NCT04614636) | Fate Therapeutics | 2020-10-17 |
| An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment (NCT04447716) | Thomas Jefferson University | 2020-10-16 |
| Islatravir and Methadone Pharmacokinetics (MK-8591-029) (NCT04568603) | Merck Sharp & Dohme LLC | 2020-10-16 |
| Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting Condition (NCT04941196) | University of Karachi | 2020-10-16 |
| A Study to Assess the Effect of Food Intake and Drug-drug Interactions of E7090 When Co-administered With Rabeprazole or Rifampin in Healthy Participants (NCT04565574) | Eisai Co., Ltd. | 2020-10-16 |
| Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Diabetic Macular Edema (NCT04772105) | Bio-Thera Solutions | 2020-10-16 |
| A Study of JNJ-77474462 (Bermekimab) in Healthy Participants of Japanese Descent Following Administration of Single Ascending Subcutaneous Doses (NCT04544826) | Janssen Research & Development, LLC | 2020-10-16 |
| CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL (NCT04049383) | Medical College of Wisconsin | 2020-10-16 |
| Effect of Ketanserin After LSD Administration (NCT04558294) | University Hospital, Basel, Switzerland | 2020-10-16 |
| EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754) (NCT04515043) | Invectys | 2020-10-16 |
| Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects (NCT04587713) | Theravance Biopharma | 2020-10-16 |
| A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 Diabetes (NCT04582435) | Novo Nordisk A/S | 2020-10-16 |
| A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors (NCT04571892) | Shanghai East Hospital | 2020-10-15 |
| A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors (NCT04472858) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2020-10-15 |
| PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer (NCT05052437) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2020-10-15 |
| Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC) (NCT04434300) | University Hospital, Caen | 2020-10-15 |
| Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan (NCT04701710) | Maria de los Angeles Peral de Bruno | 2020-10-15 |